Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Axsome Therapeutics, Inc. (AXSM) vs Bio-Techne Corp (TECH)

Axsome Therapeutics, Inc. and Bio-Techne Corp are both Biotechnology companies. Bio-Techne Corp is the larger, with a market value of $11.4B against $10.3B — 1.1× the size. Axsome Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Bio-Techne Corp trades at 62.1×. Axsome Therapeutics, Inc. grew revenue faster over the last twelve months: 56.9% against −0.38%. Bio-Techne Corp has the higher net margin (15.0% vs −24.7%) and the higher return on invested capital (7.70% vs 0.00%). Across the 18 metrics below, Bio-Techne Corp leads on 16 and Axsome Therapeutics, Inc. on 2.

Valuation

Metric AXSM TECH Biotechnology median
P/E n/m 62.06 7.88
P/S 13.01 9.32 11.47
P/B 121.31 5.37 2.52
Price to free cash flow n/m 43.02 21.16
EV/EBITDA n/m 32.27 0.74
EV/Sales 12.77 9.28 10.73
Earnings yield (1.92%) 1.61% (28.84%)
Free cash flow yield (0.71%) 2.32% (23.03%)

Profitability

Metric AXSM TECH Biotechnology median
Gross margin 93.24% 65.77% 65.16%
Operating margin (23.96%) 20.73% 0.00%
Net margin (24.68%) 14.97% 0.00%
Free cash flow margin (9.27%) 21.66% 0.00%
Return on equity (245.10%) 9.03% (57.72%)
Return on assets (27.35%) 7.07% (49.22%)
Return on invested capital 0.00% 7.70% 0.00%

Growth

Metric AXSM TECH Biotechnology median
Revenue growth (TTM) 56.87% (0.38%) 5.64%
EPS growth (last fiscal year) 38.56% 152.17% —
Revenue growth, 5-year CAGR — 5.47% 8.40%
Net income growth, 5-year CAGR 0.00% 5.31% 0.00%

Health

Metric AXSM TECH Biotechnology median
Debt to equity 1.52 0.09 0.00
Current ratio 1.43 4.55 4.73
Net debt to EBITDA 1.29 (0.19) 0.96

Dividend

Metric AXSM TECH Biotechnology median
Dividend yield — 0.37% 2.10%
Payout ratio 0.00 0.18 0.00

Size

Metric AXSM TECH Biotechnology median
Market cap 10.27b 11.38b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack